Anjana Narain was appointed Executive Vice President and General Manager of Seqirus in August 2019. With more than 25 years of experience in the pharmaceutical industry, Anjana is a global vaccines leader who has lived and worked across three continents and is a recognized champion of inclusion and diversity. Prior to joining Seqirus, Anjana spent nine years at GSK leading major businesses, including global influenza commercialization where she was responsible for the development, manufacturing and commercialization of seasonal, pandemic and cell culture programs. She started her career in market research and pharmaceutical sales at Bayer, Inc, (previously Miles Inc) USA, then at Merck & Co’s US pharma and global vaccines organizations. Anjana holds a BA from RG College in India and an MBA from the University of New Haven, and is a graduate of the General Management Program at Harvard Business School in Boston.